{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:24:10Z","timestamp":1793042650369,"version":"4.5.0"},"reference-count":81,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Participation in proton therapy (PT) trials may be affected by structural, clinical, and individual factors, potentially excluding certain patient groups. Such disparities can lead to unequal access to potential research benefits and may limit the generalisability of trial findings. This study aimed to identify factors associated with participation in a Danish randomised controlled trial (RCT) comparing proton versus photon radiotherapy for head and neck cancer.\nPatients and methods: This national cross-sectional study invited patients with pharyngeal and laryngeal cancer, referred for curative-intent radiotherapy at seven Danish radiotherapy clinics between 2022 and 2025, to complete a survey. Respondents were categorised based on enrollment status in a national RCT comparing proton versus photon radiotherapy. Clinical, demographic, psychosocial, and lifestyle data were collected and linked to clinical registry data. Multiple logistic regression was used to assess exposure variables associated with trial participation.\nResults: Of 304 respondents, 120 (39%) were enrolled in the RCT. Female gender, older age, greater geographical distance to the PT centre, mobility limitations, lower self-rated health status, and lower ability to actively engage with healthcare providers (Health Literacy Questionnaire scale 6) were significantly associated with lower odds of participation. No significant associations were observed for income, education, marital status, or anxiety.\nInterpretation: The findings indicate that demographic, geographical, functional, and communication-\u00adrelated factors may limit participation in PT trials. This highlights the need for interventions that enhance the delivery of trial information, strengthen communication between patients and healthcare professionals, and support informed clinical trial decision-making.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.43912","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:54:48Z","timestamp":1752152088000},"page":"879-888","source":"Crossref","is-referenced-by-count":4,"title":["Factors associated with participation in a proton therapy clinical trial: a cross-sectional survey of Danish patients with head and neck cancer"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5367-0794","authenticated-orcid":false,"given":"Anne Wilh\u00f8ft","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-965X","authenticated-orcid":false,"given":"Kenneth","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-6663","authenticated-orcid":false,"given":"Annesofie L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-2730","authenticated-orcid":false,"given":"Susanne O.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-6033","authenticated-orcid":false,"given":"Jesper","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-0627","authenticated-orcid":false,"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3548-3527","authenticated-orcid":false,"given":"Cai","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"117419","doi-asserted-by":"crossref","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60\u201372.","DOI":"10.1056\/NEJMra1715715"},{"key":"117420","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMra1715715","DOI":"10.1056\/NEJMra1715715"},{"key":"117421","doi-asserted-by":"crossref","unstructured":"Ingarfield K, McMahon AD, Hurley K, Toms S, Pring M, Thomas SJ, et al. Inequality in survival of people with head and neck cancer: head and neck 5000 cohort study. Head Neck. 2021;43(4):1252\u201370.","DOI":"10.1002\/hed.26589"},{"key":"117422","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/hed.26589","DOI":"10.1002\/hed.26589"},{"key":"117423","unstructured":"Olsen MH, Kj\u00e6r TK, Dalton SO. Social ulighed i kr\u00e6ft i Danmark. Kr\u00e6ftens Bek\u00e6mpelses Center for Kr\u00e6ftforskning; Copenhagen, 2019."},{"key":"117424","doi-asserted-by":"crossref","unstructured":"Olsen MH, B\u00f8je CR, Kj\u00e6r TK, Steding-Jessen M, Johansen C, Overgaard J, et al. Socioeconomic position and stage at diagnosis of head and neck cancer \u2013 a nationwide study from DAHANCA. Acta Oncol. 2015;54(5):759\u201366.","DOI":"10.3109\/0284186X.2014.998279"},{"key":"117425","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/0284186X.2014.998279","DOI":"10.3109\/0284186X.2014.998279"},{"key":"117426","doi-asserted-by":"crossref","unstructured":"Dalton SO, Olsen MH, Johansen C, Olsen JH, Andersen KK. Socioeconomic inequality in cancer survival \u2013 changes over time. A population-based study, Denmark, 1987\u20132013. Acta Oncol. 2019;58(5):737\u201344.","DOI":"10.1080\/0284186X.2019.1566772"},{"key":"117427","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2019.1566772","DOI":"10.1080\/0284186X.2019.1566772"},{"key":"117428","doi-asserted-by":"crossref","unstructured":"Jensen K, Friborg J, Hansen CR, Sams\u00f8e E, Johansen J, Andersen M, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149\u201351.","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"117429","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2020.07.037","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"117430","doi-asserted-by":"crossref","unstructured":"van der Laan HP, Van den Bosch L, Schuit E, Steenbakkers R, van der Schaaf A, Langendijk JA. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. Radiother Oncol. 2021;160:47\u201353.","DOI":"10.1016\/j.radonc.2021.04.011"},{"key":"117431","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2021.04.011","DOI":"10.1016\/j.radonc.2021.04.011"},{"key":"117432","doi-asserted-by":"crossref","unstructured":"Grau C, Durante M, Georg D, Langendijk JA, Weber DC. Particle therapy in Europe. Mol Oncol. 2020;14(7):1492\u20139.","DOI":"10.1002\/1878-0261.12677"},{"key":"117433","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/1878-0261.12677","DOI":"10.1002\/1878-0261.12677"},{"key":"117434","doi-asserted-by":"crossref","unstructured":"Friborg J, Jensen K, Eriksen JG, Sams\u00f8e E, Maare C, Farhadi M, et al. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer. Radiother Oncol. 2023;47(8):109958.","DOI":"10.1016\/j.radonc.2023.109958"},{"key":"117435","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109958","DOI":"10.1016\/j.radonc.2023.109958"},{"key":"117436","doi-asserted-by":"crossref","unstructured":"Eskander MF, Gil L, Beal EW, Li Y, Hamad A, Oppong B, et al. Access denied: inequities in clinical trial enrollment for pancreatic cancer. Ann Surg Oncol. 2022;29(2):1271\u20137.","DOI":"10.1245\/s10434-021-10868-4"},{"key":"117437","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1245\/s10434-021-10868-4","DOI":"10.1245\/s10434-021-10868-4"},{"key":"117438","doi-asserted-by":"crossref","unstructured":"Gad KT, Johansen C, Duun-Henriksen AK, Kr\u00f8yer A, Olsen MH, Lassen U, et al. Socioeconomic differences in referral to phase I cancer clinical trials: a Danish matched cancer case-control study. J Clin Oncol. 2019;37(13):1111\u201319.","DOI":"10.1200\/JCO.18.01983"},{"key":"117439","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.18.01983","DOI":"10.1200\/JCO.18.01983"},{"key":"117440","doi-asserted-by":"crossref","unstructured":"Gaito S, Aznar MC, Burnet NG, Crellin A, France A, Indelicato D, et al. Assessing equity of access to proton beam therapy: a literature review. Clin Oncol (R Coll Radiol). 2023;35(9):e528\u201336.","DOI":"10.1016\/j.clon.2023.05.014"},{"key":"117441","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.clon.2023.05.014","DOI":"10.1016\/j.clon.2023.05.014"},{"key":"117442","doi-asserted-by":"crossref","unstructured":"Burus T, VanHelene AD, Rooney MK, Lang Kuhs KA, Christian WJ, McNair C, et al. Travel-time disparities in access to proton beam therapy for cancer treatment. JAMA Netw Open. 2024;7(5):e2410670.","DOI":"10.1001\/jamanetworkopen.2024.10670"},{"key":"117443","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.10670","DOI":"10.1001\/jamanetworkopen.2024.10670"},{"key":"117444","doi-asserted-by":"crossref","unstructured":"Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL. Patient income level and cancer clinical trial participation: a prospective survey study. JAMA Oncol. 2016;2(1):137\u20139.","DOI":"10.1001\/jamaoncol.2015.3924"},{"key":"117445","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamaoncol.2015.3924","DOI":"10.1001\/jamaoncol.2015.3924"},{"key":"117446","doi-asserted-by":"crossref","unstructured":"Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, et al. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). Oncologist. 2012;17(9):1180\u201390.","DOI":"10.1634\/theoncologist.2011-0384"},{"key":"117447","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1634\/theoncologist.2011-0384","DOI":"10.1634\/theoncologist.2011-0384"},{"key":"117448","doi-asserted-by":"crossref","unstructured":"Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst. 2019;111(3):245\u201355.","DOI":"10.1093\/jnci\/djy221"},{"key":"117449","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/djy221","DOI":"10.1093\/jnci\/djy221"},{"key":"117450","doi-asserted-by":"crossref","unstructured":"Kjaer T, Johansen C, Andersen E, Karlsen R, Nielsen AL, Frederiksen K, et al. Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark. J Cancer Surviv. 2016;10(2):251\u201360.","DOI":"10.1007\/s11764-015-0471-x"},{"key":"117451","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11764-015-0471-x","DOI":"10.1007\/s11764-015-0471-x"},{"key":"117452","doi-asserted-by":"crossref","unstructured":"Ousseine YM, Bouhnik AD, Mancini J. Health literacy and clinical trial participation in French cancer patients: a national survey. Curr Oncol. 2022;29(5):3118\u201329.","DOI":"10.3390\/curroncol29050253"},{"key":"117453","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/curroncol29050253","DOI":"10.3390\/curroncol29050253"},{"key":"117454","doi-asserted-by":"crossref","unstructured":"Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, et al. \u2018When offered to participate\u2019: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst. 2021;113(3):244\u201357.","DOI":"10.1093\/jnci\/djaa155"},{"key":"117455","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/djaa155","DOI":"10.1093\/jnci\/djaa155"},{"key":"117456","doi-asserted-by":"crossref","unstructured":"Gad KT, Lassen U, Duun-Henriksen AK, Dalton SO, Mau-S\u00f8rensen M, Bidstrup PE, et al. Patients in phase 1 cancer trials: psychological distress and understanding of trial information. Acta Oncol. 2022;61(3):341\u20138.","DOI":"10.1080\/0284186X.2021.1993331"},{"key":"117457","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2021.1993331","DOI":"10.1080\/0284186X.2021.1993331"},{"key":"117458","doi-asserted-by":"crossref","unstructured":"Wilh\u00f8ft Kristensen A, Lunde Jensen A, Jensen K, Oksbjerre Dalton S, Friborg J, Grau C. Exploring patient-reported barriers to participating in proton therapy clinical trials. Tech Innov Patient Support Radiat Oncol. 2024;29:100230.","DOI":"10.1016\/j.tipsro.2023.100230"},{"key":"117459","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.tipsro.2023.100230","DOI":"10.1016\/j.tipsro.2023.100230"},{"key":"117460","doi-asserted-by":"crossref","unstructured":"Zabor EC, Kaizer AM, Hobbs BP. Randomized controlled trials. Chest. 2020;158(1S):S79\u201387.","DOI":"10.1016\/j.chest.2020.03.013"},{"key":"117461","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.chest.2020.03.013","DOI":"10.1016\/j.chest.2020.03.013"},{"key":"117462","doi-asserted-by":"crossref","unstructured":"Hansen CR, Friborg J, Jensen K, Sams\u00f8e E, Johnsen L, Zukauskaite R, et al. NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019;58(10):1410\u201315.","DOI":"10.1080\/0284186X.2019.1654129"},{"key":"117463","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2019.1654129","DOI":"10.1080\/0284186X.2019.1654129"},{"key":"117464","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"117465","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"117466","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"117467","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"117468","doi-asserted-by":"crossref","unstructured":"Overgaard J, Jovanovic A, Godballe C, Grau Eriksen J. The Danish head and neck cancer database. Clin Epidemiol. 2016;8:491\u20136.","DOI":"10.2147\/CLEP.S103591"},{"key":"117469","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/CLEP.S103591","DOI":"10.2147\/CLEP.S103591"},{"key":"117470","unstructured":"UNESCO. International Standard Classification of Education (ISCED). 2011. [cited 2025 Apr 22] Available from: https:\/\/uis.unesco.org\/sites\/default\/files\/documents\/international-standard-classification-of-education-isced-2011-en.pdf"},{"key":"117471","unstructured":"Danmarks Statistik. Income. 2025. [cited 2025 Apr 22] Available from: https:\/\/www.dst.dk\/da\/Statistik\/kommunekort\/indkomster"},{"key":"117472","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","DOI":"10.1001\/archinte.166.10.1092"},{"key":"117473","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archinte.166.10.1092","DOI":"10.1001\/archinte.166.10.1092"},{"key":"117474","doi-asserted-by":"crossref","unstructured":"Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ). BMC Public Health. 2013;13:658.","DOI":"10.1186\/1471-2458-13-658"},{"key":"117475","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/1471-2458-13-658","DOI":"10.1186\/1471-2458-13-658"},{"key":"117476","doi-asserted-by":"crossref","unstructured":"Maindal HT, Kayser L, Norgaard O, Bo A, Elsworth GR, Osborne RH. Cultural adaptation and validation of the Health Literacy Questionnaire (HLQ): robust nine-dimension Danish language confirmatory factor model. Springerplus. 2016;5(1):1232.","DOI":"10.1186\/s40064-016-2887-9"},{"key":"117477","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s40064-016-2887-9","DOI":"10.1186\/s40064-016-2887-9"},{"key":"117478","doi-asserted-by":"crossref","unstructured":"Rabin R, de Charro F, Herdman M, Gudex C, Lloyd A, Janssen M, et al. EQ-5D: a measure of health status from the EuroQol Group Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Ann Med. 2001;33(5):337\u201343.","DOI":"10.3109\/07853890109002087"},{"key":"117479","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/07853890109002087","DOI":"10.3109\/07853890109002087"},{"key":"117480","doi-asserted-by":"crossref","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","DOI":"10.1007\/s11136-011-9903-x"},{"key":"117481","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11136-011-9903-x","DOI":"10.1007\/s11136-011-9903-x"},{"key":"117482","doi-asserted-by":"crossref","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"117483","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"117484","doi-asserted-by":"crossref","unstructured":"Lilja-Fischer JK, Kristensen MH, Lassen P, Steiniche T, Tramm T, Stougaard M, et al. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer. Acta Oncol. 2023;62(11):1384\u20138.","DOI":"10.1080\/0284186X.2023.2266127"},{"key":"117485","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2023.2266127","DOI":"10.1080\/0284186X.2023.2266127"},{"key":"117486","doi-asserted-by":"crossref","unstructured":"Nowicka-Matus K, Friborg J, Hansen CR, Bernsdorf M, Elstr\u00f8m UV, Farhadi M, et al. Acute toxicities in proton therapy for head and neck cancer \u2013 a matched analysis of the DAHANCA 35 feasibility study. Clin Transl Radiat Oncol. 2024;48:100835.","DOI":"10.1016\/j.ctro.2024.100835"},{"key":"117487","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100835","DOI":"10.1016\/j.ctro.2024.100835"},{"key":"117488","unstructured":"The Danish Head and Neck Cancer Study Group. DAHANCA]. 2024. [cited 2025 May 7] Available from: https:\/\/www.dahanca.dk\/"},{"key":"117489","unstructured":"NORDCAN. Oropharynx. 2024. [cited 2025 May 15] Available from: https:\/\/gco.iarc.fr\/media\/nordcan\/factsheets\/94\/dk\/countries\/208\/oropharynx-40-danmark-208.pdf"},{"key":"117490","doi-asserted-by":"crossref","unstructured":"Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78\u201392.","DOI":"10.3322\/caac.21638"},{"key":"117491","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3322\/caac.21638","DOI":"10.3322\/caac.21638"},{"key":"117492","doi-asserted-by":"crossref","unstructured":"Thijssen SV, Boersma LJ, Heising L, Swart RR, Ou CXJ, Roumen C, et al. Clues to address barriers for access to proton therapy in the Netherlands. Radiother Oncol. 2023;178:109432.","DOI":"10.1016\/j.radonc.2022.11.021"},{"key":"117493","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.021","DOI":"10.1016\/j.radonc.2022.11.021"},{"key":"117494","doi-asserted-by":"crossref","unstructured":"Bourke S, Bennett B, Oluboyede Y, Li T, Longworth L, O\u2019Sullivan SB, et al. Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer. Health Qual Life Outcomes. 2024;22(1):81.","DOI":"10.1186\/s12955-024-02294-3"},{"key":"117495","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12955-024-02294-3","DOI":"10.1186\/s12955-024-02294-3"},{"key":"117496","doi-asserted-by":"crossref","unstructured":"Green H, Rieu R, Slevin F, Ashmore L, Bulbeck H, Gkogkou P, et al. Best practice for patient-centred radiotherapy in clinical \u00adtrials and beyond \u2013 a national multidisciplinary consensus. Clin Oncol (R Coll Radiol). 2025;39:103732.","DOI":"10.1016\/j.clon.2024.103732"},{"key":"117497","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.clon.2024.103732","DOI":"10.1016\/j.clon.2024.103732"},{"key":"117498","doi-asserted-by":"crossref","unstructured":"Trezona A, Dodson S, Osborne RH. Development of the organisational health literacy responsiveness (Org-HLR) framework in collaboration with health and social services professionals. BMC Health Serv Res. 2017;17(1):513.","DOI":"10.1186\/s12913-017-2465-z"},{"key":"117499","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12913-017-2465-z","DOI":"10.1186\/s12913-017-2465-z"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43912\/50710","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43912\/50778","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43912\/50779","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43912\/50710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:03:30Z","timestamp":1756404210000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/43912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":81,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.43912","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}